These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

222 related items for PubMed ID: 9050948

  • 1. Growth promotion and Turner-specific bone age after therapy with growth hormone and in combination with oxandrolone: when should therapy be started in Turner syndrome?
    Joss EE, Mullis PE, Werder EA, Partsch CJ, Sippell WG.
    Horm Res; 1997; 47(3):102-9. PubMed ID: 9050948
    [Abstract] [Full Text] [Related]

  • 2. Favorable final height outcome in girls with Ullrich-Turner syndrome treated with low-dose growth hormone together with oxandrolone despite starting treatment after 10 years of age.
    Stahnke N, Keller E, Landy H, Serono Study Group.
    J Pediatr Endocrinol Metab; 2002 Feb; 15(2):129-38. PubMed ID: 11874177
    [Abstract] [Full Text] [Related]

  • 3. Growth hormone in combination with anabolic steroids in patients with Turner syndrome: effect on bone maturation and final height.
    Haeusler G, Schmitt K, Blümel P, Plöchl E, Waldhör T, Frisch H.
    Acta Paediatr; 1996 Dec; 85(12):1408-14. PubMed ID: 9001649
    [Abstract] [Full Text] [Related]

  • 4. The effect of oxandrolone on voice frequency in growth hormone-treated girls with Turner syndrome.
    Menke LA, Sas TC, van Koningsbrugge SH, de Ridder MA, Zandwijken GR, Boersma B, Dejonckere PH, de Muinck Keizer-Schrama SM, Otten BJ, Wit JM.
    J Voice; 2011 Sep; 25(5):602-10. PubMed ID: 20971614
    [Abstract] [Full Text] [Related]

  • 5. Yearly stepwise increments of the growth hormone dose results in a better growth response after four years in girls with Turner syndrome. Dutch Working Group on Growth Hormone.
    van Teunenbroek A, de Muinck Keizer-Schrama SM, Stijnen T, Jansen M, Otten BJ, Delemarre-van de Waal HA, Vulsma T, Wit JM, Rouwé CW, Reeser HM, Gosen JJ, Rongen-Westerlaken C, Drop SL.
    J Clin Endocrinol Metab; 1996 Nov; 81(11):4013-21. PubMed ID: 8923853
    [Abstract] [Full Text] [Related]

  • 6. Final height outcome in girls with Turner syndrome treated with a combination of low dose oestrogen and oxandrolone.
    Bareille P, Massarano AA, Stanhope R.
    Eur J Pediatr; 1997 May; 156(5):358-62. PubMed ID: 9177976
    [Abstract] [Full Text] [Related]

  • 7. Improved final height in girls with Turner's syndrome treated with growth hormone and oxandrolone.
    Nilsson KO, Albertsson-Wikland K, Alm J, Aronson S, Gustafsson J, Hagenäs L, Häger A, Ivarsson SA, Karlberg J, Kriström B, Marcus C, Moell C, Ritzen M, Tuvemo T, Wattsgård C, Westgren U, Westphal O, Aman J.
    J Clin Endocrinol Metab; 1996 Feb; 81(2):635-40. PubMed ID: 8636281
    [Abstract] [Full Text] [Related]

  • 8. Efficacy and safety of oxandrolone in growth hormone-treated girls with turner syndrome.
    Menke LA, Sas TC, de Muinck Keizer-Schrama SM, Zandwijken GR, de Ridder MA, Odink RJ, Jansen M, Delemarre-van de Waal HA, Stokvis-Brantsma WH, Waelkens JJ, Westerlaken C, Reeser HM, van Trotsenburg AS, Gevers EF, van Buuren S, Dejonckere PH, Hokken-Koelega AC, Otten BJ, Wit JM.
    J Clin Endocrinol Metab; 2010 Mar; 95(3):1151-60. PubMed ID: 20061421
    [Abstract] [Full Text] [Related]

  • 9. Growth hormone therapy in Turner's syndrome: an update on final height. Genentech National Cooperative Study Group.
    Rosenfeld RG.
    Acta Paediatr Suppl; 1992 Sep; 383():3-6; discussion 7. PubMed ID: 1458013
    [Abstract] [Full Text] [Related]

  • 10. [Turner syndrome: a virtually certain indication for growth hormone treatment].
    Rongen-Westerlaken C, Wit JM.
    Tijdschr Kindergeneeskd; 1992 Oct; 60(5):155-63. PubMed ID: 1448805
    [Abstract] [Full Text] [Related]

  • 11. Methionyl human growth hormone and oxandrolone in Turner syndrome: preliminary results of a prospective randomized trial.
    Rosenfeld RG, Hintz RL, Johanson AJ, Brasel JA, Burstein S, Chernausek SD, Clabots T, Frane J, Gotlin RW, Kuntze J.
    J Pediatr; 1986 Dec; 109(6):936-43. PubMed ID: 3537249
    [Abstract] [Full Text] [Related]

  • 12. Final height of patients with Turner's syndrome treated with growth hormone (GH): indications for GH therapy alone at high doses and late estrogen therapy. Italian Study Group for Turner Syndrome.
    Cacciari E, Mazzanti L.
    J Clin Endocrinol Metab; 1999 Dec; 84(12):4510-5. PubMed ID: 10599710
    [Abstract] [Full Text] [Related]

  • 13. Effect of growth hormone and oxandrolone treatment on glucose metabolism in Turner syndrome. A longitudinal study.
    Joss EE, Zurbrügg RP, Tönz O, Mullis PE.
    Horm Res; 2000 Dec; 53(1):1-8. PubMed ID: 10965213
    [Abstract] [Full Text] [Related]

  • 14. [Carbohydrate metabolism in patients with Turner syndrome. The effect of therapy with growth hormone, oxandrolone and a combination of both].
    Starzyk J.
    Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2005 Dec; 11(2):79-84. PubMed ID: 15996336
    [Abstract] [Full Text] [Related]

  • 15. Six-year results of a randomized, prospective trial of human growth hormone and oxandrolone in Turner syndrome.
    Rosenfeld RG, Frane J, Attie KM, Brasel JA, Burstein S, Cara JF, Chernausek S, Gotlin RW, Kuntze J, Lippe BM.
    J Pediatr; 1992 Jul; 121(1):49-55. PubMed ID: 1625092
    [Abstract] [Full Text] [Related]

  • 16. Prospective study confirms oxandrolone-associated improvement in height in growth hormone-treated adolescent girls with Turner syndrome.
    Zeger MP, Shah K, Kowal K, Cutler GB, Kushner H, Ross JL.
    Horm Res Paediatr; 2011 Jul; 75(1):38-46. PubMed ID: 20733274
    [Abstract] [Full Text] [Related]

  • 17. Experience with growth hormone therapy in Turner syndrome in a single centre: low total height gain, no further gains after puberty onset and unchanged body proportions.
    Schweizer R, Ranke MB, Binder G, Herdach F, Zapadlo M, Grauer ML, Schwarze CP, Wollmann HA.
    Horm Res; 2000 Jul; 53(5):228-38. PubMed ID: 11150884
    [Abstract] [Full Text] [Related]

  • 18. Final height in girls with turner syndrome after long-term growth hormone treatment in three dosages and low dose estrogens.
    van Pareren YK, de Muinck Keizer-Schrama SM, Stijnen T, Sas TC, Jansen M, Otten BJ, Hoorweg-Nijman JJ, Vulsma T, Stokvis-Brantsma WH, Rouwé CW, Reeser HM, Gerver WJ, Gosen JJ, Rongen-Westerlaken C, Drop SL.
    J Clin Endocrinol Metab; 2003 Mar; 88(3):1119-25. PubMed ID: 12629094
    [Abstract] [Full Text] [Related]

  • 19. Oxandrolone for growth hormone-treated girls aged up to 18 years with Turner syndrome.
    Mohamed S, Alkofide H, Adi YA, Amer YS, AlFaleh K.
    Cochrane Database Syst Rev; 2019 Oct 30; 2019(10):. PubMed ID: 31684688
    [Abstract] [Full Text] [Related]

  • 20. Growth response and final height in Turner syndrome after combination therapy of growth hormone and anabolic steroid.
    Shu SG.
    Acta Paediatr Taiwan; 2000 Oct 30; 41(6):322-6. PubMed ID: 11198939
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.